DLDonovan J. Lott

Donovan J. Lott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Donovan J. Lott has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Krista Vandenborne

    Department of Physical Therapy, University of Florida, Gainesville, FL, USA

    7 shared publications
  • Claudia R. Senesac

    Department of Physical Therapy, University of Florida, Gainesville, FL, USA

    4 shared publications
  • Glenn A. Walter

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA

    4 shared publications
  • Sean C. Forbes

    Department of Physical Therapy, University of Florida, Gainesville, FL, USA

    4 shared publications
  • Gihan I. Tennekoon

    Department of Neurology and Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    3 shared publications
  • Glenn A. Walter

    Department of Physiology and Aging University of Florida Gainesville Florida USA

    3 shared publications

Latest Publications

  • Open Access

    Evaluation of a control paradigm allowing heart rate guided rehabilitative exercise for boys with Duchenne muscular dystrophy

    by Kimberly Stubbs, Meghana Bomma, Donovan J. Lott, Emily Griffis, Hannah M. Sweatland, Wanjiku A. Makumi, John-Anthony Coppola, Renata Shih, H. L. Sweeney, Warren Dixon, et al.

    Aerobic cycle-training counters deconditioning and induces muscle and cardiorespiratory benefits in various neuromuscular disorders. However, its applicati


  • Open Access

    Quantitative Magnetic Resonance Imaging of the Forearm in Myotonic Dystrophy Type 1

    by Sydney Eierle, Tanja Taivassalo, Hyunjun Park, Korey D. Cooke, Zahra Moslemi, Sean C. Forbes, Glenn A. Walter, Krista Vandenborne, S. H. Subramony, Donovan J. Lott

    Introduction: Myotonic dystrophy type 1 is the most prevalent muscular dystrophy in adults, characterized by weakness, impaired functional abilities, and myotonia. However, little is known about the relationship between quantitative MRI measures (fat fraction and T2 relaxation time) and clinical findings of the upper extremity. This study assessed forearm muscle structure in patients with myotonic dystrophy using quantitative MRI and correlated these measures with strength, function, and handgrip myotonia. Materials and Methods: Eighteen adults with myotonic dystrophy type 1 underwent MRI using three-point Dixon and T2 spin echo imaging of the forearm. Results: The average fat fraction and T2 relaxation time were greatest in the flexor digitorum profundus (26.7% and 55.6 ms, respectively). Correlations were found between quantitative MRI values and clinical tests of strength (r = −0.61 to −0.92, p < 0.01), function (r = −0.64 to −0.83, p < 0.01), and handgrip myotonia (r = 0.48, p < 0.05). Overall, the anterior forearm fat fraction values showed higher correlations with strength and function compared to those of the posterior forearm. Discussion: Our results support the use of quantitative MRI measures to assess forearm disease pathology and show potential to monitor the effectiveness of therapeutic treatments in patients with myotonic dystrophy type 1.


  • Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance

    by Kavya S. Nair, Donovan J. Lott, Sean C. Forbes, Alison M. Barnard, Rebecca J. Willcocks, Claudia R. Senesac, Michael J. Daniels, Ann T. Harrington, Gihan I. Tennekoon, Kirsten Zilke, et al.

    Background: Muscles of boys with Duchenne muscular dystrophy (DMD) are progressively replaced by fatty fibrous tissues, and weakness leads to loss of ambulation (LoA). Step activity (SA) monitoring is a quantitative measure of real-world ambulatory function. The relationship between quality of muscle health and SA is unknown in DMD. Objective: To determine SA in steroid treated boys with DMD across various age groups, and to evaluate the association of SA with quality of muscle health and ambulatory function. Methods: Quality of muscle health was measured by magnetic resonance (MR) imaging transverse magnetization relaxation time constant (MRI-T2) and MR spectroscopy fat fraction (MRS-FF). SA was assessed via accelerometry, and functional abilities were assessed through clinical walking tests. Correlations between SA, MR, and functional measures were determined. A threshold value of SA was determined to predict the future LoA. Results: The greatest reduction in SA was observed in the 9– < 11years age group. SA correlated with all functional and MR measures.10m walk/run test had the highest correlation with SA. An increase in muscle MRI-T2 and MRS-FF was associated with a decline in SA. Two years prior to LoA, SA in boys with DMD was 32% lower than age matched boys with DMD who maintained ambulation for more than two-year period. SA monitoring can predict subsequent LoA in Duchenne, as a daily step count of 3200 at baseline was associated with LoA over the next two-years. Conclusion: SA monitoring is a feasible and accessible tool to measure functional capacity in the real-world environment.


  • Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy

    by Donovan J. Lott, Tanja Taivassalo, Korey D. Cooke, Hyunjun Park, Zahra Moslemi, Abhinandan Batra, Sean C. Forbes, Barry J. Byrne, Glenn A. Walter, Krista Vandenborne

    Background: This two‐part study explored the safety, feasibility, and efficacy of a mild–moderate resistance isometric leg exercise program in ambulatory boys with Duchenne muscular dystrophy (DMD).Methods: First, we used a dose escalation paradigm with varying intensity and frequency of leg isometric exercise to determine the dose response and safety in 10 boys. Second, we examined safety and feasibility of a 12‐wk in‐home, remotely supervised, mild–moderate intensity strengthening program in eight boys. Safety measures included T2 MRI, creatine kinase levels, and pain. Peak strength and function (time to ascend/descend four stairs) were also measured.Results: Dose‐escalation revealed no signs of muscle damage. Seven of the eight boys completed the 12‐wk in‐home program with a compliance of 84.9%, no signs of muscle damage, and improvements in strength (knee extensors P < .01; knee flexors P < .05) and function (descending steps P < .05).Conclusions: An in‐home, mild–moderate intensity leg exercise program is safe with potential to positively impact both strength and function in ambulatory boys with DMD.


  • Walking activity in a large cohort of boys with Duchenne muscular dystrophy

    by Donovan J. Lott, Tanja Taivassalo, Claudia R. Senesac, Rebecca J. Willcocks, Ann M. Harrington, Kirsten Zilke, Hilary Cunkle, Catherine Powers, Erika L. Finanger, William D. Rooney, et al.

    Introduction: In this study we explored walking activity in a large cohort of boys with Duchenne muscular dystrophy (DMD).Methods: Step activity (monitored for 7 days), functional ability, and strength were quantified in ambulatory boys (5‐12.9 years of age) with DMD and unaffected boys. Ambulatory status was determined 2 years later.Results: Two to 5 days of activity monitoring predicted weekly step activity (adjusted R2 = 0.80‐0.95). Age comparisons revealed significant declines for step activity with increasing age, and relationships were found between step activity with both function and strength (P < .01). Our regression model predicted 36.5% of the variance in step activity. Those who were still ambulatory after 2 years demonstrated baseline step activity nearly double that of those who were no longer walking 2 years later (P < .01).Discussion: Step activity for DMD is related to and predictive of functional declines, which may be useful for clinical trials.


  • Open Access

    Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic

    by Claudia R Senesac, Alison M Barnard, Donovan J Lott, Kavya S Nair, Ann T Harrington, Rebecca J Willcocks, Kirsten L Zilke, William D Rooney, Glenn A Walter, Krista Vandenborne

    Duchenne muscular dystrophy (DMD) is a muscle degenerative disorder that manifests in early childhood and results in progressive muscle weakness. Physical therapists have long been an important component of the multidisciplinary team caring for people with DMD, providing expertise in areas of disease assessment, contracture management, assistive device prescription, and exercise prescription. Over the last decade, magnetic resonance imaging of muscles in people with DMD has led to an improved understanding of the muscle pathology underlying the clinical manifestations of DMD. Findings from magnetic resonance imaging (MRI) studies in DMD, paired with the clinical expertise of physical therapists, can help guide research that leads to improved physical therapist care for this unique patient population. The 2 main goals of this perspective article are to (1) summarize muscle pathology and disease progression findings from qualitative and quantitative muscle MRI studies in DMD and (2) link MRI findings of muscle pathology to the clinical manifestations observed by physical therapists with discussion of any potential implications of MRI findings on physical therapy management.


  • Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort

    by Sean C. Forbes, Harneet Arora, Rebecca J. Willcocks, William T. Triplett, William D. Rooney, Alison M. Barnard, Umar Alabasi, Dah-Jyuu Wang, Donovan J. Lott, Claudia R. Senesac, et al.

    In a multicenter study, MRI and hydrogen 1 MR spectroscopy demonstrated early and progressive muscle involvement of the upper extremities in participants with Duchenne muscular dystrophy. Background Upper extremity MRI and proton MR spectroscopy are increasingly considered to be outcome measures in Duchenne muscular dystrophy (DMD) clinical trials. Purpose To demonstrate the feasibi...


  • Safety And Feasibility Of Strength Training In Patients With Duchenne Muscular Dystrophy

    by Donovan J. Lott, Tanja Taivassalo, Hyun J. Park, Korey D. Cooke, Zahra Moslemi, Abhinandan Batra, Sean C. Forbes, Barry J. Byrne, Glenn A. Walter, Krista Vandenborne

  • Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy

    by Donovan J. Lott, Sean C. Forbes, Sunita Mathur, Sean A. Germain, Claudia R. Senesac, H. Lee Sweeney, Glenn A. Walter, Krista Vandenborne